You do not assist, this is a passive movement. If you feel pain in your shoulder, then Neer's test is considered positive, meaning that your pain is likely caused by impingement of the tendons or ...

Something strange is going down on Bursa Malaysia, and it’s not just your average market volatility. Several online trading accounts have been compromised and used to manipulate share prices — with ...

A wave of unauthorised trades has rocked Bursa Malaysia, raising serious concerns about the cybersecurity of online trading platforms used by investors across the country According to The Edge ...

The Securities Commission Malaysia and Bursa Malaysia this morning reassured investors that the integrity of Malaysia’s capital market remains intact following reports of unauthorised access and ...

The antibody is to treat adult recurrent or metastatic non-keratinising nasopharyngeal carcinoma (NPC) in conjunction with cisplatin or carboplatin and gemcitabine as a first-line treatment.

for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...

in combination with cisplatin or carboplatin and gemcitabine as first-line treatment for adults with certain types of nasopharyngeal carcinoma (NPC), and as a single agent for certain patients ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma. The FDA has approved Akeso’s penpulimab-kcqx, a ...

in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic non-keratinizing nasopharyngeal carcinoma (NPC). FDA also approved ...

in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic non-keratinizing nasopharyngeal carcinoma (NPC). The FDA also approved ...

in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic non-keratinizing nasopharyngeal carcinoma (NPC). FDA also approved penpulimab ...